Get to know our clinical trials
Ensayo clínico para describir la seguridad y la eficacia de TEV-56286 (Emrusolmin) en participantes con atrofia multisistémica
THE OBJECTIVE OF THIS STUDY IS TO EVALUATE THE LONG-TERM TOLERABILITY AND SAFETY OF THE INVESTIGATIONAL DRUG TEV-56286 IN PEOPLE WITH AMS.
Status
In recruitment
headquarters
Pamplona
Early phase
Technical Summary
- AN EXTENSION TRIAL TO TEST IF TEV-56286 IS EFFECTIVE IN RELIEVING MULTIPLE SYSTEM ATROPHY.
- Code EudraCT: 2025-521642-14-00
- Protocol number: TV56286-NDG-20041
- Promoter: Teva Branded
- Molecule/Drug: TEV-56286 (Emrusolmin)
- Link to Clinical Trials
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
More information about this clinical trial
Information offered by the Spanish Registry of Clinical Studies
- Summary
- Information
- Calendar
- Headquarters
- Drugs
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.